RYTM RHYTHM PHARMACEUTICALS INC
2026Q1 · CUSIP 76243J105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
285
Δ holders QoQ
+4
Breadth percentile
Top 46%
Whale holders
145
Δ whales
+3
Inst. holding value
$6.3B
New positions
63
Closed positions
59
Price momentum (1Q)
-15.3%
Put / Call
3/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 7% | +2.5% | -10.0% |
| 2025Q1 | Top 8% | +58.7% | +64.4% |
| 2024Q4 | Top 19% | +6.4% | +68.9% |
| 2023Q3 | Top 5% | +51.3% | +20.0% |
| 2023Q1 | Top 15% | +49.1% | +94.7% |
| 2022Q3 | Top 13% | +3.9% | -34.5% |
| 2022Q1 | Top 16% | +623.4% | +688.0% |
| 2020Q3 | Top 10% | +26.9% | -1.9% |
| 2018Q2 | Top 6% | -12.8% | -3.3% |
Options Sentiment
Put holders
3
QoQ: +1
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.13
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
+58.7%
Net margin
-93.3%
ROE
-164.9%
Debt ratio
46.3%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.